Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients with Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature

Pat W. Whitworth, Peter D. Beitsch, James V. Pellicane, Paul L. Baron, Laura A. Lee, Carrie L. Dul, Mary K. Murray, Mark A. Gittleman, Raye J. Budway, Rakhshanda Layeequr Rahman, Pond R. Kelemen, William C. Dooley, David T. Rock, Kenneth H. Cowan, Beth Ann Lesnikoski, Julie L. Barone, Andrew Y. Ashikari, Beth B. Dupree, Shiyu Wang, Andrea R. MenicucciErin B. Yoder, Christine Finn, Kate Corcoran, Lisa E. Blumencranz, William Audeh

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients with Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature'. Together they form a unique fingerprint.

Medicine & Life Sciences